Document Detail


Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia.
MedLine Citation:
PMID:  3805529     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The values of two Holter ambulatory electrocardiographic monitoring criteria and one programmed stimulation efficacy criterion reported to be predictive of the efficacy of amiodarone were compared in 70 patients taking amiodarone for sustained ventricular tachyarrhythmias. At baseline, all patients had ventricular tachycardia inducible by programmed stimulation. After amiodarone loading (935 +/- 271 mg for 16 +/- 7 days), efficacy was determined by a programmed stimulation criterion (ventricular tachycardia no longer inducible or less than or equal to 15 beats) and two Holter monitoring criteria (Holter I = greater than or equal to 85% reduction of ventricular premature complexes and abolition of couplets and triplets in 64 patients who had greater than or equal to 10 ventricular premature complexes/h or couplets or triplets or both before therapy; Holter II = abolition of triplets in 41 patients who had triplets before therapy). Amiodarone was effective in 12 of 70 patients by the programmed stimulation criterion, in 49 of 64 patients by Holter criterion I and in 37 of 41 patients by Holter criterion II. In assessing efficacy of amiodarone, programmed stimulation and Holter criteria were discordant in 69% of patients or more (p less than 0.001). There were 16 recurrences or sudden deaths during the entire follow-up period (19 +/- 19 months). Arrhythmia-free survival rates at 24 months of patients with efficacy and inefficacy by each criterion, respectively, were 90 and 78% by programmed stimulation, 84 and 62% by Holter criterion I (p less than 0.05) and 73 and 50% by Holter criterion II (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
S G Kim; S D Felder; I Figura; D R Johnston; L E Waspe; J D Fisher
Related Documents :
2401059 - Top-resolution frequency analysis of electrocardiogram with adaptive frequency determin...
6209319 - Comparative electrophysiologic effects of intravenous and oral procainamide in patients...
20191699 - Effectiveness of catheter ablation of ventricular tachycardia in elderly patients with ...
2301219 - Interrelationship of variable coupling, multiformity and repetitive forms: implications...
6849269 - Electrophysiologic testing in the management of survivors of out-of-hospital cardiac ar...
18304999 - Arrhythmogenic right ventricular dysplasia-cardiomyopathy and provocable coved-type st-...
25330689 - Evaluation of the utility of baseline serum hepatic and renal testing in pregnant patie...
2335779 - Ostomy prolapse in paraplegic patients: etiology, prevention, and treatment.
22832289 - Interleukin 1β blockade improves signs and symptoms of chronic calcium pyrophosphate c...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  9     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1987 Feb 
Date Detail:
Created Date:  1987-03-06     Completed Date:  1987-03-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  398-404     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Amiodarone / administration & dosage,  therapeutic use*
Anti-Arrhythmia Agents / administration & dosage
Cardiac Pacing, Artificial / methods*
Cardiomyopathy, Hypertrophic / physiopathology
Coronary Disease / physiopathology
Drug Therapy, Combination
Electrocardiography / methods*
Evaluation Studies as Topic
Female
Follow-Up Studies
Humans
Male
Middle Aged
Tachycardia / drug therapy*,  physiopathology
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 1951-25-3/Amiodarone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A nonflow basis for the vulnerability of the subendocardium.
Next Document:  Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest an...